Tissue Microarray Sampling Strategy for Prostate Cancer Biomarker Analysis
暂无分享,去创建一个
[1] Gleason Df. Classification of prostatic carcinomas. , 1966 .
[2] H Stein,et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.
[3] K. Griffiths,et al. Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters , 1992, The Prostate.
[4] H. Moch,et al. Ki67 LABELLING INDEX: AN INDEPENDENT PREDICTOR OF PROGRESSION IN PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY , 1996, The Journal of pathology.
[5] J W Moul,et al. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. , 1996, The Journal of urology.
[6] P. Steeg,et al. Cancer prognostics: Past, present and p27 , 1997, Nature Medicine.
[7] H. Moch,et al. Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer. , 1998, Human pathology.
[8] A. Cnaan,et al. Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma. , 1998, American journal of clinical pathology.
[9] M. Kattan,et al. Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery. , 1998, Cancer.
[10] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[11] M. Rifkin,et al. The prognostic significance of proliferation‐associated nucleolar protein p120 expression in prostate adenocarcinoma , 1999, Cancer.
[12] M. Rubin,et al. Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression. , 2000, Human pathology.
[13] M. Rubin,et al. Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men. , 2000, Journal of the National Cancer Institute.
[14] K. Pienta,et al. Expression of nuclear antigen Ki-67 in prostate cancer needle biopsy and radical prostatectomy specimens. , 2000, Journal of the National Cancer Institute.
[15] Daniel S. Miller,et al. Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. , 2000, Archives of pathology & laboratory medicine.
[16] S. Dhanasekaran,et al. Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.
[17] Holger Moch,et al. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade , 2001, The Journal of pathology.
[18] C. Cordon-Cardo,et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. , 2001, The American journal of pathology.
[19] C. Sheehan,et al. Prognostic factors in prostate cancer. , 2003, American journal of clinical pathology.